Skip navigation
7th Annual Clinical Data Disclosure, Transparency & Dissemination promo banner
Patient Registries, Real World Evidence and HEOR promo banner
Medicare Pricing & Contracting Congress promo banner
PAP 2020 – 21st Annual Patient Assistance and Access Programs promo banner

FDA Issues Draft Guidance to Foster Competitive Access for Bioequivalence Studies

The guidance seeks to help generic and biosimilar drug sponsors gain access to reference products from brand-name manufacturers.
Published Date: 
December 4, 2014
URL: 
http://www.biopharminternational.com/biopharm/News/FDA-Issues-Draft-Guidance-to-Foster-Competitive-Ac/ArticleStandard/Article/detail/862723?contextCategoryId=435&ref=25
Title: 
FDA Issues Draft Guidance to Foster Competitive Access for Bioequivalence Studies
Short Description: 
The guidance seeks to help generic and biosimilar drug sponsors gain access to reference products from brand-name manufacturers.